SC Filed 2020-06-09 Event — SEC 0001193125-20-164768 →

Satter Muneer A → AILERON THERAPEUTICS INC RNTX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

9 13D/G filings on this issuer

8 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.11

590,758 shares short · -9.3% vs prior

Other 13D/G Filings on AILERON THERAPEUTICS INC

Filed	Form	Filer	Stake	Shares
2026-08-14	SCHEDULE 13G	ADAR1 Capital Management, LLC	—	—	view →
2021-01-08	SC	Satter Muneer A	—	—	view →
2020-04-16	SC	Novartis Bioventures Ltd	—	—	view →
2020-04-13	SC	Novartis Bioventures Ltd	—	—	view →
2020-03-18	SC	Novartis Bioventures Ltd	—	—	view →
2019-08-13	SC	Lilly Ventures Fund I LLC	—	—	view →
2019-04-03	SC	Novartis Bioventures Ltd	—	—	view →
2019-03-18	SC	Novartis Bioventures Ltd	—	—	view →

Other Filings by Satter Muneer A

Filed	Form	Issuer	Stake	Shares
2021-11-12	SC	Aadi Bioscience, Inc. WHWK	—	—	view →
2021-01-08	SC	AILERON THERAPEUTICS INC RNTX	—	—	view →
2020-11-23	SC	Aerpio Pharmaceuticals, Inc. WHWK	—	—	view →
2019-01-11	SC	Aerpio Pharmaceuticals, Inc. WHWK	—	—	view →
2019-01-11	SC	Akebia Therapeutics, Inc. AKBA	—	—	view →
2018-07-03	SC	Akebia Therapeutics, Inc. AKBA	—	—	view →
2018-07-03	SC	Aerpio Pharmaceuticals, Inc. WHWK	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →